Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Scientists discover how a 'sociable' protein can hold clues about Alzheimer's origin

Scientists discover how a 'sociable' protein can hold clues about Alzheimer's origin

Microglial surveillance helps prevent seizure activity in the brain

Microglial surveillance helps prevent seizure activity in the brain

New clue to protect neurons and encourage their growth found

New clue to protect neurons and encourage their growth found

Genetic differences play a vital role in early diagnosis of Alzheimer's disease

Genetic differences play a vital role in early diagnosis of Alzheimer's disease

Melatonin and its metabolites promote the formation of long-term memories

Melatonin and its metabolites promote the formation of long-term memories

Testing memory over four weeks could help identify the earliest signs of Alzheimer's disease

Testing memory over four weeks could help identify the earliest signs of Alzheimer's disease

Study connects specific foods to later-in-life cognitive acuity

Study connects specific foods to later-in-life cognitive acuity

Scientists shed light on how neurons form long-term memories

Scientists shed light on how neurons form long-term memories

Measuring a tau fragment in plasma can help predict future cognitive decline in elderly people

Measuring a tau fragment in plasma can help predict future cognitive decline in elderly people

WHO highlights leading causes of mortality and morbidity worldwide from 2000 to 2019

WHO highlights leading causes of mortality and morbidity worldwide from 2000 to 2019

Mice study identifies action mechanism of a promising drug against Alzheimer's disease

Mice study identifies action mechanism of a promising drug against Alzheimer's disease

Study reveals new biomarker for amyotrophic lateral sclerosis

Study reveals new biomarker for amyotrophic lateral sclerosis

Head injuries and long sleep deprivation can affect neurogenerative processes

Head injuries and long sleep deprivation can affect neurogenerative processes

Study sheds new light on how brain encodes time and place into memories

Study sheds new light on how brain encodes time and place into memories

Researchers identify new gene variants that modify the risk of late-onset Alzheimer's disease

Researchers identify new gene variants that modify the risk of late-onset Alzheimer's disease

Researchers use advanced methods to investigate structure and interactions of proteins

Researchers use advanced methods to investigate structure and interactions of proteins

RNA mutations within common bacterium linked to invasive meningococcal disease

RNA mutations within common bacterium linked to invasive meningococcal disease

COVID-19 crisis increases burden of dementia caregivers

COVID-19 crisis increases burden of dementia caregivers

Novel form of tau in spinal fluid indicates the stage of Alzheimer’s disease

Novel form of tau in spinal fluid indicates the stage of Alzheimer’s disease

New biomarker of Alzheimer's may lead to enhanced diagnostic methods

New biomarker of Alzheimer's may lead to enhanced diagnostic methods

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.